Bausch Health Companies | Des Atouts



Assets Changement Date
Amgen USD 91.84B 956M 2024-12
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 26.54B 45M 2024-09
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Danaher USD 77.54B 3.07B 2024-12
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
Novo Nordisk 397.44B 28.06B 2024-09
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Prestige Brands USD 3.33B 12.61M 2024-12
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Zoetis USD 14.24B 120M 2024-12



Bausch Health Companies Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.